K. Skubitz

Patched Homolog 1 (PTCH1) Mutation in a CIC-Rearranged Sarcoma: Lack of Response to the Smoothened (SMO) Vismodegib
20231 citationsauthor #3
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
20232 citationsauthor #11
Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal Myofibroblasts
20223 citationsauthor #1
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy
202211 citationsauthor #6
Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide
20225 citationsauthor #1
Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide
20221 citationsauthor #1
A Novel Tongue-Based Tumor With an RREB1-MRTFB Fusion: Variant Rhabdomyosarcoma or Aggressive Variant of Ectomesenchymal Chondromyxoid Tumor
20222 citationsauthor #7
Primary angiosarcoma of the spleen, a rare indication for splenectomy: a case report
202110 citationsauthor #3
Pegylated liposomal doxorubicin-induced renal toxicity in retroperitoneal liposarcoma: a case report and literature review
202112 citationsauthor #5
Multiple malignant tumors in a patient with familial chordoma, a case report
20210 citationsauthor #5
Multiple malignant tumors in a patient with familial chordoma, a case report
20211 citationsauthor #5
27066 Angiosarcoma of the scalp and paraneoplastic encephalopathy: Multidisciplinary approach to diagnosis and treatment
20210 citationsauthor #5
Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4
202023 citationsauthor #4
Tu2048 PRIMARY ANGIOSARCOMA OF THE SPLEEN: A RARE INDICATION FOR SPLENECTOMY
20200 citationsauthor #4
Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum
202037 citationsauthor #4
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
202047 citationsauthor #2
Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand–foot syndrome: a newly recognized toxicity
20198 citationsauthor #6
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma
201918 citationsauthor #1
Long-term Outcome After Doxorubicin and Ifosfamide Overdose in a Patient With Osteosarcoma and BARD1 Mutation.
20194 citationsauthor #2
Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors.
20197 citationsauthor #1
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
2019191 citationsauthor #9
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
201917 citationsauthor #3
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma
201825 citationsauthor #8
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
201795 citationsauthor #1
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate‐grade or high‐grade liposarcoma
201775 citationsauthor #5
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.
201712 citationsauthor #15
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value
201731 citationsauthor #1
Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors
20164 citationsauthor #1
1,25-dihydroxyvitamin D hypercalcemia and imatinib hepatotoxicity in a patient with GIST
20160 citationsauthor #2
Recurrence of a small gastric gastrointestinal stromal tumor with high mitotic index
20160 citationsauthor #3
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
201689 citationsauthor #4
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin (PLD): Use of left ventricular ejection fraction (EF).
20160 citationsauthor #1
discriminative methods Analysis of molecular profile data using generative and
20150 citationsauthor #11
Response of Aneurysmal Bone Cyst to Denosumab
201555 citationsauthor #1
Lymphoma of the hands in a patient with rheumatoid arthritis: case report.
20145 citationsauthor #3
Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas
201411 citationsauthor #1
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study
201460 citationsauthor #5
A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas.
20143 citationsauthor #11
Giant Cell Tumor of Bone: Current Treatment Options
2014103 citationsauthor #1
Response to treatment with denosumab in patients with giant cell tumor of bone (GCTB): FDG PET results from two phase 2 trials.
20147 citationsauthor #1
An absolute obstacle: cardiac metastasis of synovial sarcoma.
20142 citationsauthor #5
An Unusual Case of Ewing Sarcoma: A Middle-aged Woman With Multiple Recurrences Over 36 Years
20140 citationsauthor #4
Prediction of metastatic behavior in high-grade pleomorphic soft tissue sarcomas by gene expression.
20130 citationsauthor #1
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours
201324 citationsauthor #7
Qualitative disorders of leukocytes
20138 citationsauthor #2
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
2013508 citationsauthor #12
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity
201328 citationsauthor #9
Relationship of FAP-alpha, ADAM12, WISP1, and SOX11 expression to tumor activity in aggressive fibromatosis: Demonstration of heterogeneity within and between cases.
20130 citationsauthor #8
Gene expression identifies heterogeneity of metastatic propensity in high‐grade soft tissue sarcomas
201223 citationsauthor #1
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.
201233 citationsauthor #4
Table of Contents for (9789048129171) Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma by Hayat, M. A
20110 citationsauthor #11
Denosumab safety and efficacy in giant cell tumor of bone (GCTB): Interim results from a phase II study.
201114 citationsauthor #12
Pancreas Cancer Molecular Targets for Therapy
20111 citationsauthor #6
Primary Cancer Site
20110 citationsauthor #6
Two new synthetic peptides from the N‐domain of CEACAM1 (CD66a) stimulate neutrophil adhesion to endothelial cells
201115 citationsauthor #1
Denosumab Treatment for Giant Cell Tumor of Bone (GCTB) in Adolescent Patients: Interim Results From a Phase II Study
20110 citationsauthor #6
Population Candidate Gene Association Study
20110 citationsauthor #6
PtdIns 3-kinase
20111 citationsauthor #6
Heterogeneity of metastatic behavior among high-grade pleomorphic soft tissue sarcomas identified by gene expression analysis.
20110 citationsauthor #1
Conventional protein kinase C plays a critical role in negative regulation of CD98-induced homotypic aggregation.
20102 citationsauthor #3
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.
2010661 citationsauthor #3
Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors
201059 citationsauthor #11
Subgroups of Ovarian Carinoma: Identification Using Differential Gene Expression
20101 citationsauthor #2
Giant cell tumour of bone
200989 citationsauthor #2
Correlation of FDG PET-CT with histologic response after neoadjuvant chemotherapy for soft tissue sarcomas.
20093 citationsauthor #5
Denosumab for the treatment of giant cell tumor (GCT) of bone: Final results from a proof-of-concept, phase II study.
200911 citationsauthor #3
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors
200943 citationsauthor #2
CEACAM-1, -3, -6, and -8 Signaling in Human Neutrophils
20081 citationsauthor #1
Denosumab treatment of giant cell tumor of bone: Interim analysis of an open-label phase II study
200820 citationsauthor #3
Early detection of ovarian cancer using group biomarkers
200837 citationsauthor #4
Inhibition of T-Cell Activation by a CEACAM1 (CD66a) Peptide
20080 citationsauthor #1
Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells
200865 citationsauthor #1
Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma
200752 citationsauthor #2
Combination of pegylated-liposomal doxorubicin (PLD) and bevacizumab (B) (PLD-B) in sarcoma (SAR)
20074 citationsauthor #1
Group-Biomarkers Identification in Ovarian Carcinoma
20075 citationsauthor #4
Giant cell tumor of the uterus: case report and response to chemotherapy
200719 citationsauthor #1
GROUP-BIOMARKERS IDENTIFICATIONINOVARIAN CARCINOMA
20070 citationsauthor #1
Uncovering potential biomarkers in ovarian carcinoma via biclustering of DNA microarray data
20064 citationsauthor #4
Differential gene expression identifies subgroups of ovarian carcinoma.
200639 citationsauthor #4
Differential gene expression identifies subgroups of renal cell carcinoma.
200649 citationsauthor #1
Gene expression identifies heterogeneity of soft tissue sarcomas.
20060 citationsauthor #1
A differential biclustering algorithm for comparative analysis of gene expression
20061 citationsauthor #4
Combination of bevacizumab (A) and pegylated-liposomal doxorubicin (PLD) (PLD-A) in sarcoma (SAR).
20063 citationsauthor #2
The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils
200548 citationsauthor #3
Paclitaxel and pegylated‐liposomal doxorubicin are both active in angiosarcoma
2005198 citationsauthor #1
Differential Gene Expression in Liposarcoma, Lipoma, and Adipose Tissue
200540 citationsauthor #1
Subcelluar Distribution of Myeloid-Related Protein 8 (MRP8) and MRP14 in Human Neutrophils.
20050 citationsauthor #3
A phase I study of paclitaxel poliglumex (PPX) in combination with cisplatin (CIS) for patients (pts) with advanced cancer
20052 citationsauthor #1
Gene expression in giant-cell tumors.
200441 citationsauthor #1
Oral glutamine to prevent chemotherapy stomatitis : A pilot study induced
20040 citationsauthor #1
Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells
200479 citationsauthor #3
The role of micro-array gene analysis in the biology of renal cell cancer
20040 citationsauthor #1
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
2004136 citationsauthor #7
Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers
200433 citationsauthor #4
Gene expression in giant cell tumors.
200451 citationsauthor #1
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
2004277 citationsauthor #3
Role of gene expression arrays in sarcomas
20047 citationsauthor #1
Gene expression in aggressive fibromatosis.
200471 citationsauthor #1
Differential gene expression in ovarian carcinoma: identification of potential biomarkers.
2004236 citationsauthor #2
Characterization of sarcomas by means of gene expression.
200439 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT